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ABSTRACT
RNA editing of miRNAs, especially in the seed region,
adds another layer to miRNA mediated gene regula-
tion which can modify its targets, altering cellular sig-
naling involved in important processes such as dif-
ferentiation. In this study, we have explored the role
of miRNA editing in CD4+ T cell differentiation. CD4+
T cells are an integral component of the adaptive im-
mune system. Naı¨ve CD4+ T cells, on encountering
an antigen, get differentiated either into inflammatory
subtypes like Th1, Th2 or Th17, or into immunosup-
pressive subtype Treg, depending on the cytokine
milieu. We found C-to-U editing at fifth position of
mature miR-100, specifically in Treg. The C-to-U edit-
ing of miR-100 is functionally associated with at least
one biologically relevant target change, from MTOR
to SMAD2. Treg cell polarization by TGF1 was re-
duced by both edited and unedited miR-100 mimics,
but percentage of Treg in PBMCs was only reduced
by edited miR-100 mimics, suggesting a model in
which de-repression of MTOR due to loss of unedited
mir-100, promotes tolerogenic signaling, while gain
of edited miR-100 represses SMAD2, thereby limiting
the Treg. Such delicately counterbalanced systems
are a hallmark of immune plasticity and we propose
that miR-100 editing is a novel mechanism toward
this end.
INTRODUCTION
CD4+ T cells are important players of the adaptive immune
response; they are helper T cells that provide help to B-cells
to generate antibody response, to CD8+ T cells to regu-
late its cytotoxic response and so on. Naı¨ve CD4+ T cells
upon encountering an antigen, get differentiated into differ-
ent subsets, depending on the antigen and cytokine milieu
generated by cells of the innate immune system (1). They get
differentiated toTh1, in response to intracellular pathogens,
into Th2 in response to helminthes infection, and into Th17
against extracellular bacteria and fungi (2). In addition, to
these inflammatory effector subsets, it has been found that
naı¨ve CD4+ T cells can also differentiate into iTreg in the
periphery; iTreg (induced regulatory T cells) are immuno-
suppressive T-helper subset, similar in function to natural
Treg (nTreg) generated in the thymus. There are other T-
helper subsets like Th9, Th22, Tfh (follicular helper), etc.
which are being defined based on the distinct combina-
tion of cytokines they secrete (1). Moreover, various re-
ports have suggested that these T-helper subsets also retain
the ability to convert into other subsets depending on the
cytokine environment (3). This trans-differentiation of Th
subsets is important in a disease scenario, where conver-
sion of one subset to another could rescue or exacerbate the
disease condition, depending on the subset being formed.
For example, conversion of an inflammatory subset to an
immunosuppressive one, can subdue an auto-immune like
disease condition or vice-versa can be useful in an immune-
compromised condition such as in cancer, where inflamma-
tory cells are needed to combat the infection. The inter-
conversion of these subsets has been reviewed in peer ar-
ticles (3,4). Among all the subsets, Treg is considered to be
the most flexible one, with the ability to convert to any sub-
set depending on their cytokine milieu. Thus, in order to
overcome any infection/pathogen, balance of inflammatory
CD4+ T cells and immunosuppressive Treg is very crucial.
MicroRNAs (miRNAs) are 20–22 nt long non-coding
RNAs that play an important role in the fine tuning of gene
expression. miRNAs bind to 3′UTR of the mRNAs and
interfere with the gene expression by either degrading the
mRNA or inhibiting translation (5). In some cases, they
can also increase the gene expression by interacting with
RNAbinding proteins likeHuR, FXR, etc. or by binding to
5′UTR of the gene and activating translation (6). miRNAs
have been known to be crucial mediators in regulating T cell
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activation and T cell effector differentiation and function
(7). Editing ofmiRNAs adds another layer to the regulation
of miRNA function, with or without change in its expres-
sion. miRNA editing refers to the change in the sequence
of miRNA without any change in the genome information,
as a post-transcriptional processing. There are two known
enzymes responsible for canonical miRNA editing; ADAR
(adenosine deaminase acting on RNA) causes adenonsine
(A) to inosine (I) editing and APOBEC (apolipoprotein
B mRNA editing enzyme, catalytic polypeptide like) that
deaminates cytosine (C) to uracil (U). These two editing
events are well studied (8). ADAR1 and APOBEC1/3 ex-
pression has also been previously shown in CD4+ T cells
(9,10). A-to-I editing generally occurs on the dsRNA struc-
ture formed in the primary (pri)-miRNAs. Depending on
the position of editing, it could alter the processing of the
given miRNA, thereby affecting the miRNA expression
(11,12). In some cases, miRNA editing occurs in seed re-
gion of the mature miRNA, which may not affect its ex-
pression level but could change its target choice and bind-
ing efficiency. Kawahara et al. have shown that the brain
specific editing of miR-376a-5p in its seed region alters its
targets. The edited miR-376a-5p regulates uric acid level in
the brain by repressing phosphoribosyl pyrophosphate syn-
thetase 1 which is involved in uric acid synthesis pathway
(13). Later, Choudhury et al. have shown that a decrease
in the level of editing of miR-376a-5p can increase invasive-
ness and migration of glioblastoma cells and is therefore as-
sociated with high grade gliomas (14). miRNA editing thus
plays an important role in altering any disease condition by
fine tuning the gene expression.
miRNAs being smaller in size, easy to deliver in vivo and
natural components of gene regulation, can be an impor-
tant therapeutic tool (15). Studies of miRNAs in T cell dif-
ferentiation are mainly focused on differentially expressed
or unique miRNAs present in a particular subset. To our
knowledge, this is the first report focusing on the role of
miRNA editing in CD4+ T cell differentiation and main-
tenance. In this study, we have performed miRNA profiling
in the in vitro differentiated CD4+ T cell subsets using next
generation sequencing. miRNA profiling data were further
analyzed for miRNAs editing. Among various canonically
edited miRNAs, miR-100 was found to be edited from C-
to-U in its seed region, specifically in Treg as compared to
other subsets. The editing alters the miR-100 targets, which
further affect Treg differentiation and lineage maintenance.
Thus, C-to-U editing in the miR-100 may represent a coun-
terbalancing switch for fine-tuning Treg lineage commit-
ment.
MATERIALS AND METHODS
Sample collection
Cord blood was obtained from St. Stephan’s hospital,
Delhi, India. A formal ethical clearance certificate, to col-
lect the human cord sample, was obtained from the hos-
pital ethics committee. The cord blood was collected from
healthy individuals during both normal and caesarian de-
liveries. PBMCs (peripheral blood mononuclear cells) were
isolated from healthy individuals and cultured in RPMI
with 10% FBS, 1g/ml of PHA (Sigma Aldrich) and 20
ng/ml of rhIL-2 (R&D Systems).
Naı¨ve CD4+ T isolation and differentiation
The cord blood mononuclear cells (CBMCs) and PBMCs
were isolated by layering whole blood on histopaque (Sigma
Aldrich) containing tubes, in 1:1 ratio. Tubes were cen-
trifuged at 400g for 30 min and the buffy coat formed at
intersection of plasma (top layer) and histopaque (middle
layer) was collected. CD4+ naı¨ve T cells were isolated from
CBMCs using Miltenyi human CD4+ naı¨ve T cell isolation
kit as per manufacturer’s instructions and percentage purity
was confirmed by flow cytometry as described below. These
CD4+ naı¨ve T cells were cultured overnight in X-vivo-15
media (Lonza) with 10% fetal bovine serum (FBS), 1g/ml
PHA and 20 ng/ml rIL2 (R&D systems); in case of Th17,
FBS was not added. The naı¨ve CD4+ T cells were polar-
ized in above media with 1 g/ml soluble anti-CD3 (Sigma
Aldrich), 1 g/ml anti-CD28 (Sigma Aldrich) and in addi-
tion other recombinants and antibodies were added specific
to the subset being polarized as follows: Th1, 5ng/ml rhIL-
12, 1g/ml anti-human IL4; Th2, 20 ng/ml rhIL4, anti-
human 1g/ml IFN ; Th17, 10ng/ml each of rhIL6, rhIL-
1, rhIL21, rhIL23, rhTNF, 1ng/ml rhTGF1, 1g/ml
anti-human IL4, 1g/ml anti-human IFN ; Treg, 1ng/ml
rhTGF1. All the recombinants and antibodies were pur-
chased from BD Biosciences.
Flow cytometry
All the polarized subsets were induced with 20 ng/ml
PMA (Sigma Aldrich), 1 M ionomycin (Sigma Aldrich)
and monensin (BD Biosciences) for 4 h after 6 days. A
fraction of cells was preserved in Trizol for RNA isola-
tion and other set was used for flow cytometry staining.
Cell surface staining was done with anti-human CD4-APC
(BD), anti-human CD45RA-FITC (BD) for naı¨ve CD4+
T cells. The cells were later permeabilized and intracellu-
lar staining was done for anti-human IL4-PE-Cy7 (eBio-
science), anti-human IFN -Alexa Fluor 488 (BD), anti-
human IL17A-PE (eBioscience), anti-human IL17F-Alexa
Fluor 647 (eBioscience), anti-human Foxp3-FITC (BD).
Flow cytometry was performed on BD FACS calibur and
data were analyzed using CellQuest Pro and FlowJo soft-
ware.
RNA isolation and sequencing
RNA was isolated using Trizol (Life Techonologies) ac-
cording to manufacturer’s instructions. Quality of RNA
was checked on Bioanalyzer and those with RNA integra-
tion number (RIN) above 8 were sent for miRNA profil-
ing. Numbers of biological replicates sent for miRNA se-
quencing were 3 for Tnaive, Th2, Th17, Treg each and 2
for Th1. miRNA library preparation and sequencing was
outsourced to OcimumBiosolutions, Hyderabad, India. Li-
brary preparation was done using TruSeq small RNA sam-
ple preparation kit and sequencing was done on Illumina
HiSeq 2000 with single end read length of 50bp.
The editing site was validated using ABI SNaPshot mul-
tiplex kit as per manufacturer’s instructions using reverse
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primer for pre-mir-100. Briefly, the pre-mir-100 was ampli-
fied and later it was used as template to enrich the edited
mir-100 using forward primer whose 3′ end was specific
for the edited nucleotide in mir-100. The polymerase chain
reaction (PCR) product obtained was purified using Ex-
oSAP method and genotyped using ABI SNaPshot multi-
plex reagents.
miRNA editing analysis pipeline
miRNA editing analysis was done using publicly available
pipeline (16), briefly described in Supplementary Figure S1.
The single nucleotide polymorphisms (SNP)were filtered by
using dbSNP build 138. Among the edited miRNAs, only
those miRNAs were studied whose total read count was
greater than or equal to 10.
In silico target prediction
In silico target prediction for unedited and edited hsa-miR-
100 was done using Target Scan Custom (Release 5.2, June
2011) by putting 7-mer seed sequence from 2 to 8 nu-
cleotides as input (17).
Cloning of MTOR and SMAD2 3′UTRs
The complete 3′UTR (914 nt) ofMTOR and first 600bp of
SMAD2 3′UTR (8720 nt), were cloned inXho1-Not1 site of
psiCHECK-2 vector (Promega). List of primers is given in
Supplementary Table S1.
Transfection and luciferase assay
250ng of MTOR and SMAD2 3′UTR psiCHECK-2 plas-
mids were transfected with 40nM of scrambled control,
unedited or edited miR-100 mimics in HeLa cell line, us-
ing Lipofectamine 2000 as per manufacturer’s instructions.
Luciferase assay was done after 24 h of transfection us-
ing Dual-luciferase reporter assay system (Promega) as per
manufacturer’s instruction (18). To determine the effect of
unedited and editedmiR-100 onMTOR and SMAD2RNA
and protein levels, 200 nM of both unedited and edited
miR-100 mimics were transfected in HeLa cell line. The
RNA or total protein extract were prepared 24 h post-
transfection. Themimics were purchased fromDharmacon,
Thermo Scientific.
CD4+ naı¨ve T cells were activated overnight with PHA
and rhIL2 and were transfected next day with 500 nM of
scrambled control, unedited miR-100 or edited-miR-100
mimics as day 1. The cells were re-transfected on day 4
of Treg polarization and analyzed on day 5 by flow cy-
tometer as done by Simpson et al. (19). The transfection
was done using Lipofectamine 2000 (Life Technologies) in
complete media according to manufacturer’s instructions.
PBMCs were also activated overnight with PHA and rhIL2
and then transfected similarly and analyzed after 48 hours.
Quantitation by real time PCR
RNA from cell line was isolated using RNeasy Plus mini
kit (Qiagen). RNA was quantified on NanoDrop 1000
(Thermo Scientific). cDNA was prepared from 2 g of
RNA using ABI high capacity cDNA synthesis kit. Real-
time PCR was done using SYBR FAST qPCR master mix
(Kapa) as per manufacturer’s instruction on LightCycler
480 II system (Roche). The relative transcripts were calcu-
lated using comparative threshold cycle (Ct) method. The
primers sequences are given in Supplementary Table S1.
Western blot
Total protein extract was prepared and run on 8% SDS-
PAGE, PVDF membrane as described in (20). The mem-
brane was probed with following antibodies: MTOR
(1:1000, Cell Signaling), SMAD2 (1:2000, Cell Signaling)
and -actin (1:2000, Sigma Aldrich). The proteins were de-
tected using SuperSignal West Pico Chemiluminescent sub-
strate (Thermo Scientific) according to the manufacturer’s
instruction. Densitometry was done using AlphaEaseFC
software.
Mathematical modeling
Differential equation model of CD4+ T cell proliferation
and differentiation was made. It was assumed that the rate
of T cell proliferation is higher than the rate of differentia-
tion (21). In the absence of sufficient evidences it was further
assumed that the effect of unedited and edited miR-100 on
the kinetics of T cell proliferation and differentiation respec-
tively is same. The differential equations were modeled for
three different scenarios as described in Figure 4. All the
simulations were performed using Berkley Madonna (22).
Runge–Kutta 4 method was used to perform the iterations.
The simulation time was set to 1000 time units. The data
were recorded in intervals of 0.02 units.
We obtained the following differential equations:
d(Tp)
dt
= k
mi R
Tp − kd1 ∗ Tp
d(Td)
dt
= k
c ∗ emi RTp − kd2 ∗ Td
Tp and Td are the number of T cells and Treg cells at time
t. There initial count was taken as 100 and zero units, re-
spectively. The rate constant for T cell proliferation (k) was
calculated to be 0.05775 a.u taking generation time as 12 h.
The dead rate kd1 and kd2 were estimated by multiple simu-
lations. The amount of unedited miR-100 (miR) and edited
miR-100 (emiR) was estimated the same way. The constant
c was introduced to take into account the lag between T-
cell proliferation and differentiation. The estimated values
for each scenario are given in the table.
Conditions Tp Td Kd1 Kd2 miR emiR c
1 100 0 10−7 *Tp 5*10−8 1 1 10
2 100 0 10−7 *Tp 5*10−8 1 3.7 10
3 100 0 10−7 *Tp 5*10−8 3.7 1 10
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RESULTS
Naı¨ve CD4+ T cells were polarized in vitro into different sub-
sets
To obtain naı¨ve CD4+ T cells, cord blood was used, as it
is a rich source of immature monocytes and lymphocytes.
Naı¨ve CD4+ T cells were obtained as described in Materi-
als and Methods. The percentage recovery of naı¨ve CD4+
T cells was determined by estimating CD4+ CD45RA+ T
cells by flow cytometry (Figure 1A). The cells obtained were
found to be ≥ 97% double positive. Further, naı¨ve CD4+ T
cells were activated overnight and next day, were either ter-
minated as Th0 or polarized into different subsets namely
Th1, Th2, Th17 and Treg using various cytokines, as per the
schematic presentation (Figure 1B). The percentage polar-
ization of each subset was validated by flow cytometry at the
end of 6 days, before isolating their RNA. The flow cytom-
etry of the representative subsets are shown in Figure 1C.
The polarized Th1 were found to be majorly expressing its
signature cytokine, i.e. IFN ; Th2, IL4; Th17, IL17A and
IL17F; and lastly Treg expressed Foxp3. Thus, the CD4+
T subsets were successfully polarized. Later, the total RNA
was isolated from polarized and Th0 cells and sequenced
for small RNA.
miR-100 was found to be specifically edited in Treg
The small RNA sequencing data were analyzed to deter-
mine themiRNAs that were edited in each subset. The anal-
ysis was done as described in Materials and Methods. We
found approximately 2% of the total miRNAs to be edited
inmost of the subsets (Supplementary Figure S2).We found
many non-canonical editing sites, but since theirmechanism
is not known, we confined this analysis to the canonical
editing only (Supplementary Table S2). The percentage of
canonical edited sites i.eA-to-I andC-to-U, among the total
miRNAs edited, is represented in Figure 2A and B, respec-
tively. Further, we screened for canonical edited miRNAs in
their seed sequence, as it can affect its target binding ability
and subsequently the signaling pathway in which the tar-
get is involved. The percentage of A-to-I and C-to-U edited
miRNAs in the seed region in all the subsets is shown in
Figure 2C and D, respectively.
Further, we focused on miRNAs with canonical editing
in the seed sequence and shortlisted only those where the
same event was found in at least two out of three biologi-
cal replicates for each sample. Among them, four miRNAs
were observed to be differentially edited namely, miR-100
(C-to-U), miR-411, miR-381 and miR-589 (A-to-I) (Fig-
ure 2E). Among the differentiated subsets, only miR-100
was edited specifically in Treg and thus was selected for fur-
ther studies.
miR-100 editing in Treg was also validated by SNaP-
shot primer extensionmethod as discussed inMaterials and
Methods. The edited peak was observed at a higher level in
Treg as compared to Th0 (Supplementary Figure S3). The
edited site was also detectable in Th0, probably due to some
non-specific amplification and/or presence of small level of
editing in Th0whichwas not detectable by our experimental
and analysis pipeline.
C-to-U editing in miR-100 changes its target fromMTOR to
SMAD2
Target prediction for unedited and edited miR-100 was
done using Target ScanHumanCustom.We found no over-
lap among the targets predicted for unedited and edited
miR-100, indicating that a single base change in the seed
sequence can dramatically affect its target binding ability
(Figure 3A). Among the predicted targets, we focused on
those genes that are involved inCD4+ T cell biology.MTOR
was found to be a validated target for unedited miR-100
(23) and SMAD2 was the predicted target of edited miR-
100, involved in CD4+ T cell differentiation and function.
The complementarity binding of both the unedited and
edited miR-100 to their respective targets is shown in Fig-
ure 3B. The 3′UTR ofMTOR and SMAD2 were cloned in
psiCHECK-2 plasmid in 3′UTR of Renilla luciferase and
were transfected along with unedited and edited miR-100
mimics in easily transfectable HeLa cell line to validate the
binding. The unedited miR-100 was found to targetMTOR
but not SMAD2, while on editing, miR-100 could bind to
SMAD2 and not MTOR 3′UTR as depicted by their rel-
ative luciferase levels (Figure 3C). Further, unedited and
edited miR-100 mimics were transfected in HeLa cells to
determine the effect on MTOR and SMAD2 RNA and
protein, by real-time PCR and western blot, respectively.
The transfection of unedited and edited miR-100 was vali-
dated by measuring their expression at the RNA level (Sup-
plementary Figure S4). The expression of SMAD2 RNA
was low in edited miR-100 mimics transfected cells as com-
pared to scrambled control (Figure 3D), whereas there was
no effect on MTOR transcript in any condition. However,
at the protein level, MTOR was decreased upon transfec-
tion of unedited miR-100 mimics and the transfection of
edited miR-100 mimics led to a decrease in the expression
of SMAD2 (Figure 3E and F). This suggests that unedited
miR-100 inhibits the MTOR gene expression by blocking
translation, without affecting the mRNA whereas edited
miR-100 degrades the SMAD2 mRNA. Thus, unedited
miR-100 decreases MTOR expression but not SMAD2 ex-
pression, which gets reversed when C-to-U editing occurs in
its seed region. In conclusion, editing of miR-100 in its seed
region at position 5 of mature miRNA, changes its target
fromMTOR to SMAD2.
Unedited and edited miR-100 regulate Treg differentiation
Since MTOR and SMAD2 are both important in Treg for-
mation, we simulated the effects of miR-100 in a hypothet-
ical model where naı¨ve T cells proliferate through activa-
tion of MTOR but need activation of SMAD2, the effec-
tor of TGF1, to commit to a Treg lineage. Thus, we di-
vided CD4+ T cell differentiation in two phases: prolifer-
ative phase and differentiation phase. The change in both
proliferation and differentiation due to change in the level
of unedited and editedmiR-100was derivedmathematically
as shown in Figure 4A. The levels of unedited and edited
miR-100 were simplistically modeled as either low or high
in three different scenarios, where Tp and Td are number
of CD4+ T cells and Tregs, respectively. In first condition
where both unedited and edited miR-100 were low, Tp-1
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Figure 1. CD4+ T cell polarization into Th1, Th2, Th17 and Treg subsets. (A) CD4+ T naı¨ve were isolated from cord blood and validated by analyzing
naı¨ve T cell marker, i.e. CD4+ CD45RA+ by flow cytometry. (B) Schematic showing the polarization of CD4+ T naı¨ve into different subsets using specific
polarizing media and detected by the expression of exclusive cytokines and transcription factors. (C) Percentage polarization of representative Th1, Th2,
Th17 and Treg as determined by flow cytometry at the end of sixth day. The cells were gated on CD4+ T cells.
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Figure 2. miRNAs edited among different CD4+ T cell subsets. (A) Per-
centage of A-to-I editing among the edited miRNAs in different CD4+ T
cells. (B) Percentage of C-to-U editing among the edited miRNAs in dif-
ferent CD4+ T cells. (C) Percentage of A-to-I editing in the seed region
among different CD4+ T cells. (D) Percentage of C-to-U editing in seed re-
gion among different CD4+ T cells. (E)List of miRNAs undergoing A-to-I
or C-to-U editing in the seed region of the mature miRNAs.
increases exponentially and so does Td-1 after a few di-
visions; in second condition where unedited miR-100 was
low and edited miR-100 was high, Tp-2 remains same but
Td-2 decreases. Lastly, in third condition where unedited
miR-100 was high, Tp-3 decreases and so does Td-3, ir-
respective of the level of edited miR-100. This model can
be considered to have two brake points - suppression of
MTOR by unedited miR-100, blocking expansion of un-
committed T cells and suppression of SMAD2 by edited
miR-100, blocking Treg commitment. The model explains
why large reductions in miR-100 would be necessary for lin-
eage commitment, as seen by us (Supplementary Figure S5).
In confirmation, transfection of unedited miR-100 mimics
at day 1 and day 4 of Treg polarization led to reduced frac-
tions of CD4+ Foxp3+ Treg cells as compared to scrambled
control (Figure 4B). The edited miR-100 led to a greater
reduction in Treg formation than unedited miR-100. The
transfection efficiency in primary T cell culture was found
to be around 95% (Supplementary Figure S6). In differenti-
ated T cells, such as PBMC cultured in proliferating condi-
tions, edited but not unedited miR-100 decreased the Treg
fraction (Figure 4C), which is consistent with SMAD2 as
the effector for lineage commitment. Moreover, expression
of pSMAD2/3 was found to be significantly decreased in
PBMCs transfected with edited miR-100 mimics but not in
Figure 3. C-to-U editing in miR-100 changes its target from MTOR to
SMAD2. (A) Venn diagram showing the number of predicted targets of
unedited and edited miR-100 using Target Scan Custom. (B) Comple-
mentarity binding of MTOR 3′UTR and SMAD2 3′UTR to unedited
and edited miR-100, respectively. (C)Relative Renilla luciferase activity of
MTOR or SMAD2 3′UTR luciferase construct co-transfected with scram-
bled or unedited or editedmiR-100mimics normalized to Firefly luciferase
activity. (D) Relative level of MTOR and SMAD2 transcripts after 24
h of transfection with scrambled or unedited or edited miR-100 mim-
ics, normalized by GAPDH. (E) Representative western blot for MTOR,
SMAD2 and ACTB protein levels after 24 h of transfection with scram-
bled, unedited and edited miR-100 mimics. (F) Densitometry analysis of
the western blot in (D) was done using AlphaEase FC. Data are represen-
tative of four independent experiments, *P < 0.01, using two tailed t-test.
unedited miR-100 mimics transfected cells (Figure 4D), in-
dicating the downregulation of TGF signaling.
DISCUSSION
Editing of miRNA has recently been shown to regulate
gene expression and thus could involve in cellular differen-
tiation and function. In the present study, we intended to
look for the role of miRNA editing in CD4+ T cell differ-
entiation or function, as differentially expressed miRNAs
are already known to regulate CD4+ T cell lineage mainte-
nance (7). This is the first study that has explored the role
of miRNA editing in CD4+ T cell biology. We found that
the level of editing in CD4+ T cell subsets is very low as
compared to that in the brain. Around 2% of total miR-
NAs were found to be edited in mostly all of the CD4+ T
cell subsets. However, since the polarized T cell subsets are
heterogenous (Figure 1C), the actual percentages of edited
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Figure 4. Both unedited and edited miR-100 mimics decrease Treg differentiation. (A). Graphical representation of cell number with time using mathemat-
ical modeling in different conditions depending on unedited and edited miR-100 levels during Treg differentiation. Tp represents number of CD4+ T cells
and Td number of Tregs. 1, 2 and 3 represent different levels of unedited and edited miR-100 as shown in the table. (B) The representative percentages of
CD4+Foxp3+ T cells transfected with scrambled, unedited and edited miR-100 mimics during in vitro Treg differentiation and their respective percentage
decrease. (C) The representative percentages of CD4+Foxp3+ T cells in PBMCs transfected with scrambled, unedited and edited miR-100 mimics and
their respective percentage decrease. (D) The representative percentages of CD4+ pSMAD2/3+ T cells in PBMCs transfected with scrambled, unedited
and edited miR-100 mimics and their respective percentage decrease. The cells were gated on CD4+. Data are representative of at least three independent
experiments, *P < 0.01, two tailed t-test.
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Figure 5. Proposed model for role of miR-100 editing in Treg differentia-
tion and maintenance. miR-100 on C-to-U editing at fifth position result
in change of target from MTOR to SMAD2. We propose a model where
unedited miR-100 inhibits MTOR, limiting T cell proliferation and hence
its differentiation whereas edited miR-100 inhibits SMAD2 affecting Treg
differentiation and lineage commitment. Thus, editing of miR-100 act as a
control switch to limit Treg differentiation.
miRNA in a pure population may be higher than estimated
by us. Among the editedmiRNAs, we focused only onA-to-
I or C-to-U editing events that occur in seed region of the
mature miRNAs. Interestingly, we found mir-30 family to
be edited, non-canonically, at various positions in different
subsets. mir-30e was edited at position 35 of pre-miRNA
in all the subsets, but this editing position does not lie in
the seed region of the miRNA indicating that the editing
might affect the processing of the miRNA rather than its
target binding ability. In addition, we also observed U-to-
C editing in mir-30e at position 33 in two samples, namely
Th2 and Treg, indicating that mir-30e is differentially edited
with respect to its position and editing type among the sub-
sets. Similarly, mir-30a and mir-30d were among the com-
mon miRNAs which had undergone editing. Thus, mir-30
family might be involved in regulating T cell differentiation.
In addition, the unique editing event(s) occurring in Th0 is
A-to-I in mir-381; in Th17 is U-to-C inmir-30d andU-to-G
in mir-27b.
We narrowed down to miR-100 which is specifically
edited in Treg because we were interested in miRNA
edited in the differentiated subsets only. The editing type
found in miR-100 was C-to-U at fifth position of mature
miRNA which was validated by SNaPshot primer exten-
sion method. Most of the previous studies were focused
mainly on the ADAR mediated editing, i.e. A-to-I; while
very few studies discussed the C-to-U editing in miRNAs
(24). While APOBEC1 and 3 have both been reported pre-
viously to be present in T cells (9,10), further studies will
be needed to determine the precise mechanism of miR-100
editing. To determine the effect of miR-100 editing, targets
for both unedited and edited miRNAs were determined in
silico. The predicted targets of unedited and edited miR-
100were found to be completely different, signifying the im-
portance of a single base change in the seed region. One of
the targets for unedited miR-100 wasMTOR and for edited
miR-100 SMAD2, relevant to CD4+ T cell biology. MTOR
is a known target of unedited miR-100; in T cells it gets ac-
tivated by PI3K signaling, which in turn gets activated by
IL2R or CD28 or other co-stimulatory signaling molecules,
in response to environmental cues like antigen, cytokines
secreted by innate immunity, availability of nutrients, etc.
(25). Thus, on T cell activation, MTOR gets activated and
causes T cell proliferation and differentiation. The edited
miR-100, present exclusively in Treg, targets SMAD2which
is involved in TGF1 signaling required for Treg differenti-
ation (26). Due to limitation in number of cells in human
primary culture, we validated the target of unedited and
edited miR-100 in easily transfectable HeLa cell lines fol-
lowed by confirmation of pSMAD2/3 downregulation in
PBMCs transfected by edited miR-100.
To determine the biological significance of edited miR-
100, we transfected both unedited and editedmiR-100mim-
ics during Treg differentiation and in already differentiated
Treg in PBMCs. Transfection of unedited and edited miR-
100 mimics during Treg differentiation resulted in a de-
crease in polarization of Treg as measured by percentage of
CD4+ Foxp3+ cells. The decrease was more in edited miR-
100 mimic transfected cells as compared to unedited miR-
100 mimic transfected ones. These observations are consis-
tent with a model where there are two brake points in Treg
formation; first, inhibition of MTOR by unedited miR-100
limits CD4+ T cell proliferation and second, inhibition of
SMAD2 by editedmiR-100 limits Treg lineage commitment
(Figure 5). Both regulatory systems need to be overcome
duringTreg differentiation from immature T cells while only
the second needs to be overcome in differentiated T cells.
While this simplistic model functions well in in vitro polar-
ization conditions, the full story is likely to be more com-
plex as role of MTOR in Treg is controversial. Powell et
al. reviewed the role of MTOR in T cell differentiation and
mentioned that in vitro differentiated Treg, as described in
our study, have high levels of MTOR. They further divided
Treg into two populations based on the expression level of
MTOR; namely, short lived effector Treg, with highMTOR
level and long lived memory Treg cells with low MTOR
level, depending on their cellularmetabolism (27). This con-
tradicts the previous reports which suggest rapamycin, an
inhibitor of MTOR promote Treg differentiation while in-
hibiting other T effectors (28,29). Thus, while we found that
unedited miR-100 mimics did not have much effect on the
percentage of Tregs in PBMC culture, there may be impor-
tant changes in their properties. Further, edited miR-100
mimics modestly decreased the Treg fraction despite PBMC
representing a differentiated state; possibly indicating that
edited miR-100 makes Treg flexible to convert to other sub-
types. This effect is likely to be due to the downregulation
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of SMAD2 since Treg polarized from Smad2 cKO mice are
shown to be more plastic in vitro as compared to control
mice (30). We speculate that decrease in miR-100 is an im-
portant step in T cell proliferation, since this was seen in
all lineages. Further, in cells undergoing Treg transforma-
tion, editing of miR-100 leads to new targeting of SMAD2.
This is expected to be a counterbalancing process, which
restrains unchecked expansion of Tregs and promotes plas-
ticity. This is a potentially important regulatory mechanism
for tolerogenic immune responses and miRNA editing mer-
its further exploration in such contexts.
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